Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ricardo L.B. Costa"'
Autor:
Elie Barakat, MD, Andras Bibok, MD, Anupam Rishi, MD, Altan Ahmed, MD, Jessica M. Frakes, MD, Sarah E. Hoffe, MD, Avan J. Armaghani, MD, Aixa E. Soyano, MD, Ricardo L.B. Costa, MD, Ghassan El-Haddad, MD, Junsung Choi, MD, Bela Kis, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 1, Pp 100838- (2022)
Purpose: Our purpose was to retrospectively evaluate the safety and efficacy of transarterial hepatic radioembolization (TARE) treatment with yttrium-90 labeled glass microspheres in patients with chemotherapy-refractory breast cancer with liver-domi
Externí odkaz:
https://doaj.org/article/2f74ad0e84814633ae43295babdba3e2
Autor:
Kamran A. Ahmed, MD, Youngchul Kim, PhD, John A. Arrington, MD, Sungjune Kim, MD, PhD, Michelle DeJesus, BS, Aixa E. Soyano, MD, Avan J. Armaghani, MD, Ricardo L.B. Costa, MD, Hung T. Khong, MD, Loretta S. Loftus, MD, Marilin Rosa, MD, Jimmy J. Caudell, MD, PhD, Roberto Diaz, MD, PhD, Timothy J. Robinson, MD, PhD, Arnold B. Etame, MD, PhD, Nam D. Tran, MD, PhD, Solmaz Sahebjam, MD, Hatem H. Soliman, MD, Brian J. Czerniecki, MD, PhD, Peter A. Forsyth, MD, H. Michael Yu, MD, Hyo S. Han, MD
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 6, Pp 100798- (2021)
Purpose: We hypothesize treatment with nivolumab and stereotactic radiosurgery (SRS) will be feasible and well tolerated, and may improve intracranial tumor control rates compared with SRS alone. Methods and Materials: The study was designed as a pro
Externí odkaz:
https://doaj.org/article/d3a069d067ee48fd8facf6e4317a3b58
Publikováno v:
Case Reports in Oncology, Vol 10, Iss 3, Pp 992-997 (2017)
Breast cancer is the most common tumor among women, and approximately 6% of the patients have de novo metastatic breast cancer. Occult breast cancer accounts for only 0.1–0.8% of the cases and most commonly presents with axillary lymphadenopathy. S
Externí odkaz:
https://doaj.org/article/ce36b201180440fab6018e8582001770
Publikováno v:
Journal of Global Oncology, Vol 3, Iss 4, Pp 281-284 (2017)
Externí odkaz:
https://doaj.org/article/322464bd352145bc895f2f4a68d67ec0
Publikováno v:
Clinical Breast Cancer. 23:378-387
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73d98976197a3c14957a233e06f73b1b
https://doi.org/10.1016/j.clbc.2023.01.013
https://doi.org/10.1016/j.clbc.2023.01.013
Autor:
Roberto Diaz, Susan J. Hoover, Ricardo L.B. Costa, Amber G. Orman, G.Q. Yang, Kamran Ahmed, C. Liveringhouse, Christine Laronga, Daniel E. Oliver, Nazanin Khakpour, Matthew N. Mills
Publikováno v:
European Journal of Cancer. 98:48-58
Triple negative breast cancer (TNBC) is an aggressive disease, but recent studies have identified heterogeneity in patient outcomes. However, the utility of histologic subtyping in TNBC has not yet been well-characterised. This study utilises data fr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca91eb461b1b76fe99a59b28462bf907
https://doi.org/10.1016/j.ejca.2018.04.011
https://doi.org/10.1016/j.ejca.2018.04.011
Autor:
Costa RLB; Ricardo L.B. Costa, H. Lee Moffitt Cancer Center, Tampa, FL; and William J. Gradishar, Northwestern University, Chicago, IL., Gradishar WJ; Ricardo L.B. Costa, H. Lee Moffitt Cancer Center, Tampa, FL; and William J. Gradishar, Northwestern University, Chicago, IL.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2018 Mar 10; Vol. 36 (8), pp. 725-727. Date of Electronic Publication: 2018 Jan 26.